Front-line therapy for advanced colorectal cancer: emphasis on chemotherapy.

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Seminars in Oncology

• Publication date

  2005-12-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1053/J.SEMINONCOL.2005.04.022PMID 16399430
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• FOLFIRI Followed by FOLFOX6 or the Reverse Sequence in Advanced Colorectal Cancer: A Randomized GERCOR Study

  2023cited by this paper
• Cancer Statistics, 2005

  2005cited by this paper
• FOLFIRI followed by FOLFOX6 or the reverse sequence in advanced colorectal cancer: a randomized GERCOR study.

  2004cited by this paper
• OPTIMOX study: FOLFOX 7/LV5FU2 compared to FOLFOX 4 in patients with advanced colorectal cancer.

  2004cited by this paper
• A randomized controlled trial of fluorouracil plus leucovorin, irinotecan, and oxaliplatin combinations in patients with previously untreated metastatic colorectal cancer.

  2004cited by this paper
• Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer.

  2004cited by this paper
• Comparison of oral capecitabine versus intravenous fluorouracil plus leucovorin as first-line treatment in 605 patients with metastatic colorectal cancer: results of a randomized phase III study.

  2001cited by this paper
• Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer. Irinotecan Study Group.

  2000cited by this paper
• Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trial.

  2000cited by this paper
• Clinical implications of dihydropyrimidine dehydrogenase (DPD) deficiency in patients with severe 5-fluorouracil-associated toxicity: identification of new mutations in the DPD gene.

  2000cited by this paper
• Efficacy of intravenous continuous infusion of fluorouracil compared with bolus administration in advanced colorectal cancer.

  1998cited by this paper
• Randomised trial of irinotecan plus supportive care versus supportive care alone after fluorouracil failure for patients with metastatic colorectal cancer.

  1998cited by this paper
• Randomised trial of irinotecan versus fluorouracil by continuous infusion after fluorouracil failure in patients with metastatic colorectal cancer.

  1998cited by this paper
• [Oxaliplatin, folinic acid and 5-fluorouracil (folfox) in pretreated patients with metastatic advanced cancer. The GERCOD].

  1997cited by this paper
• Oxaliplatin with high-dose leucovorin and 5-fluorouracil 48-hour continuous infusion in pretreated metastatic colorectal cancer.

  1997cited by this paper
• Oxaliplatine, acide folinique et 5-fluorouracile (folfox) en seconde ligne thérapeutique du cancer colorectal métastasé

  1997cited by this paper
• Randomised comparison of combination chemotherapy plus supportive care with supportive care alone in patients with metastatic colorectal cancer.

  1993cited by this paper

• Surrogacy of Recurrence-free Survival for Overall Survival as an Endpoint of Clinical Trials of Perioperative Adjuvant Therapy in Hepatobiliary-pancreatic Cancers

  2023influential citation
• Mapeamento de fatores clínicos preditivos da neuropatia sensorial periférica induzida por oxaliplatina: revisão sistemática

  2021cites this paper
• Antineoplastic compounds in the environment—substances of special concern

  2016cites this paper
• Molecular profiling of childhood cancer: Biomarkers and novel therapies

  2014cites this paper
• Durable complete responses in metastatic colorectal cancer treated with chemotherapy alone.

  2011cites this paper
• Imaging Intratumoral Convection: Pressure-Dependent Enhancement in Chemotherapeutic Delivery to Solid Tumors

  2009cites this paper
• Do cytotoxic chemotherapy drugs discharged into rivers pose a risk to the environment and human health? An overview and UK case study

  2008cites this paper
• Oxaliplatin-induced immune hemolytic anemia: a case report and review of the literature.

  2007cites this paper
• Decreased Expression of Gene Cluster at Chromosome 1q21 Defines Molecular Subgroups of Chemoradiotherapy Response in Esophageal Cancers

  2007cites this paper
• Metastectomy for combined hepatic and extrahepatic colorectal cancer metastases

  2007cites this paper
• Number of Disected Lymph Nodes In Colorectal Cancer Patients Submitted To Radical Surgery: The Quality of Oncology Treatment

  2006cites this paper
• Récepteurs tyrosine kinase et cancérologie digestive : perspectives thérapeutiques

  2006cites this paper
• Phase II study on stereotactic body radiotherapy of colorectal metastases

  2006cites this paper
• Pharmacogenetics and irinotecan therapy.

  2006cites this paper
• Thymidylate synthase as a chemotherapeutic drug target: Where are we after fifty years?

  2006cites this paper
• Fatal and Nonfatal Hemorrhagic Complications of Living Kidney Donation

  2006cites this paper
• Peritoneal Carcinomatosis of Colorectal Origin: Standard of Care

  2006cites this paper